- Home
- PBBK vs MRSN Comparison
PBBK vs MRSN Comparison
Compare PBBK & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- MRSN
- Stock Information
- Founded
- PBBK 1919
- MRSN 2001
- Country
- PBBK United States
- MRSN United States
- Employees
- PBBK N/A
- MRSN N/A
- Industry
- PBBK Banks
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- MRSN Health Care
- Exchange
- PBBK Nasdaq
- MRSN Nasdaq
- Market Cap
- PBBK 45.2M
- MRSN 40.7M
- IPO Year
- PBBK N/A
- MRSN 2017
- Fundamental
- Price
- PBBK $18.02
- MRSN $0.29
- Analyst Decision
- PBBK
- MRSN Strong Buy
- Analyst Count
- PBBK 0
- MRSN 5
- Target Price
- PBBK N/A
- MRSN $5.75
- AVG Volume (30 Days)
- PBBK 4.6K
- MRSN 2.8M
- Earning Date
- PBBK 08-13-2025
- MRSN 08-12-2025
- Dividend Yield
- PBBK N/A
- MRSN N/A
- EPS Growth
- PBBK 12.16
- MRSN N/A
- EPS
- PBBK 0.83
- MRSN N/A
- Revenue
- PBBK $12,804,000.00
- MRSN $34,006,000.00
- Revenue This Year
- PBBK N/A
- MRSN N/A
- Revenue Next Year
- PBBK N/A
- MRSN $1.30
- P/E Ratio
- PBBK $22.57
- MRSN N/A
- Revenue Growth
- PBBK 5.21
- MRSN N/A
- 52 Week Low
- PBBK $13.85
- MRSN $0.26
- 52 Week High
- PBBK $19.05
- MRSN $2.83
- Technical
- Relative Strength Index (RSI)
- PBBK 66.45
- MRSN 41.92
- Support Level
- PBBK $16.49
- MRSN $0.33
- Resistance Level
- PBBK $19.05
- MRSN $0.37
- Average True Range (ATR)
- PBBK 0.59
- MRSN 0.03
- MACD
- PBBK 0.14
- MRSN -0.00
- Stochastic Oscillator
- PBBK 91.23
- MRSN 1.24
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.